Evidence map›Paper›PMID 39658862›Full record

Trial reportJAMA2025

Electronic Sepsis Screening Among Patients Admitted to Hospital Wards: A Stepped-Wedge Cluster Randomized Trial.

Yaseen M Arabi, Abdulmohsen Alsaawi, Mohammed Alzahrani, Ali M Al Khathaami, Raed H AlHazme, Abdullah Al Mutrafy, Ali Al Qarni, Ramesh Kumar Vishwakarma, Rasha Al Anazi, Eman Al Qasim and 38 more

2 registry-linked trialsAbstract readComparative StudyMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in JAMA, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 24 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04078594 nacompletednot on this map

Stepped-wedge Cluster Randomized Controlled Trial of Electronic Early Notification of Sepsis in Hospitalized Ward Patients (SCREEN)

TypeinterventionalSponsorKing Abdullah International Medical Research CenterRan2019 to 2022Enrolled65,250ConditionsSepsisArmssepsis e-alert
NCT07397689 recruitingnot on this mapstarted 2026, after this paper: background citation

Sepsis Optimal Recognition Toolkit in Children (SORT): An Early Recognition Tool for Children in Asia

Typeobservational_patient_registrySponsorKK Women's and Children's HospitalRan2026 to 2028Enrolled40,000ConditionsInfection, SepsisArmsApplication of the Phoenix Sepsis Score
3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. [S3 guideline on sepsis-prevention, diagnosis, therapy, and follow-up care-update 2025].Medizinische Klinik, Intensivmedizin und Notfallmedizin · 2025
    Guideline
  5. Trial
  6. Factors Associated With Mortality Among Septic Hospital Ward Patients.Mayo Clinic proceedings. Innovations, quality & outcomes · 2026
    Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Current standard of care for septic shock.Intensive care medicine · 2026
    Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

48 authors.

Yaseen M ArabiIntensive Care Department, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Abdulmohsen AlsaawiKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Mohammed AlzahraniMedical Services, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Jeddah, Saudi Arabia.
Ali M Al KhathaamiKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Raed H AlHazmeKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Abdullah Al MutrafyKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Ali Al QarniMedical Services, King Abdulaziz Hospital, Ministry of National Guard Health-Affairs, Al Ahsa, Saudi Arabia.
Ramesh Kumar VishwakarmaBiostatistics and Bioinformatics Department, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Rasha Al AnaziKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Eman Al QasimIntensive Care Department, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Sheryl Ann AbdukahilIntensive Care Department, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Fawaz K Al-RabeahKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Huda Al GhamdiKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Abdulaleem AlatassiKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Hasan M Al-DorziIntensive Care Department, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Fahad Al-HameedKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Razan BabakrQuality and Patient Safety Department, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Jeddah, Saudi Arabia.
Abdulaziz A AlghamdiKing Abdullah International Medical Research Center, Al Ahsa, Saudi Arabia.
Salih Bin SalihKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Ahmad AlharbiKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Mufareh Edah AlKatheriKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Hani MustafaKing Abdullah International Medical Research Center, Al Ahsa, Saudi Arabia.
Saad Al-QahtaniIntensive Care Department, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Shaher Al QahtaniQuality and Patient Safety Department, Imam Abdulrahman Al Faisal Hospital Ministry of National Guard-Health Affairs, Dammam, Saudi Arabia.
Nahar AlselaimKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Nabiha TashkandiKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Ali H AlyamiKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Zeyad AlyousefKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Omar AlDibasiBiostatistics and Bioinformatics Department, King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Abdul Hadi Al-QahtaniKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Abdulaziz AldawoodIntensive Care Department, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Angela CaswellKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Nouf Al AyadhiKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Hadeel Al RehailiKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Ahmed Al ArfajMedical Services, King Abdulaziz Hospital, Ministry of National Guard Health-Affairs, Al Ahsa, Saudi Arabia.
Hatami Al MubarakMedical Services Department, Imam Abdulrahman Al Faisal Hospital, Ministry of National Guard-Health Affairs, Dammam, Saudi Arabia.
Turki AlwasaidiMedical Services Department, Prince Mohammed Bin Abdulaziz Hospital, Ministry of National Guard-Health Affairs, Madinah, Saudi Arabia.
Saleh ZahraniQuality and Patient Safety Department, Prince Mohammed Bin Abdulaziz Hospital, Ministry of National Guard-Health Affairs, Madinah, Saudi Arabia.
Yousef AlalawiDepartment of Medicine, Prince Mohammed Bin Abdulaziz Hospital, Ministry of National Guard-Health Affairs, Madinah, Saudi Arabia.
Abdulrahman AlhadabKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Tariq NasserKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Tagwa OmerKing Abdullah International Medical Research Center, Jeddah, Saudi Arabia.
Sameera M Al JohaniKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Abdulaziz AlajlanKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Musharaf SadatIntensive Care Department, King Abdulaziz Medical City, Ministry of National Guard-Health Affairs, Riyadh, Saudi Arabia.
Mohammed AlzunitanKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
Saad Al MohrijKing Abdullah International Medical Research Center, Riyadh, Saudi Arabia.
SCREEN Trial Group and the Saudi Critical Care Trials Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Importance: Sepsis screening is recommended among hospitalized patients but is supported by limited evidence of effectiveness. Objective: To evaluate the effect of electronic sepsis screening, compared with no screening, on mortality among hospitalized ward patients. Design, Setting, and Participants: In a stepped-wedge, cluster randomized trial at 5 hospitals in Saudi Arabia, 45 wards (clusters) were randomized into 9 sequences, 5 wards each, to have sepsis screening implemented at 2-month periods. The study was conducted between October 1, 2019, and July 31, 2021, with follow-up through October 29, 2021. Intervention: An electronic alert, based on the quick Sequential Organ Failure Assessment score, was implemented in the electronic medical record in a silent mode that was activated to a revealed mode for sepsis screening. Main Outcomes and Measures: The primary outcome was 90-day in-hospital mortality. There were 11 secondary outcomes, including code blue activation, vasopressor therapy, incident kidney replacement therapy, multidrug-resistant organisms, and Clostridioides difficile. Results: Among 60 055 patients, 29 442 were in the screening group and 30 613 in the no screening group. They had a median age of 59 years (IQR, 39-68), and 30 596 were male (51.0%). Alerts occurred in 4299 of 29 442 patients (14.6%) in the screening group and 5394 of 30 613 (17.6%) in the no screening group. Within 12 hours of the alert, patients in the screening group were more likely to have serum lactate tested (adjusted relative risk [aRR], 1.30; 95% CI, 1.16-1.45) and intravenous fluid ordered (aRR, 2.17; 95% CI, 1.92-2.46) compared with those in the no screening group. In the primary outcome analysis, electronic screening resulted in lower 90-day in-hospital mortality (aRR, 0.85; 95% CI, 0.77-0.93; P < .001). Screening reduced vasopressor therapy and multidrug-resistant organisms but increased code blue activation, incident kidney replacement therapy, and C difficile. Conclusions and Relevance: Among hospitalized ward patients, electronic sepsis screening compared with no screening resulted in significantly lower in-hospital 90-day mortality. Trial Registration: ClinicalTrials.gov Identifier: NCT04078594.

Indexed as

Clostridium InfectionsElectronic Health RecordsHospital MortalityMass ScreeningSepsisAdultAgedClostridioides difficileFemaleFollow-Up StudiesHumansLactic AcidMaleMiddle AgedOrgan Dysfunction ScoresRenal Replacement TherapyLactic AcidVasoconstrictor Agents

Identifiers

PMID39658862
PMCPMC11880955

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.